Q3 PAT up 55%, 9M revenue up 21%, new Ethiopia subsidiary, office shifted

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹446.20

prior close

₹456.20

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.3%-0.5% vs market

Hospital peers, median of 22sector+0.6%+0.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.3

10m

-2.0

15m

-1.8

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+1.3-0.5+0.6+0.3

Next day

+2.9+0.3+2.6-0.2+3.1

+0.9-0.5+1.3+0.7+0.1

+2.6+2.1+0.5+2.7-0.1

+1.8+3.1-1.3+2.9-1.2

+3.1+2.6+0.5+6.2-3.2

+2.0+0.6+1.4+4.3-2.3

15d

+0.6-1.4+2.1+6.0-5.3

-2.8-6.9+4.2+3.6-6.4

-4.8-7.7+2.9+3.2-7.9

+1.5+7.0-5.4+6.0-4.5

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 total income up 21.8% YoY at Rs 540 Cr; PAT up 54.5% at Rs 44 Cr. 9M FY26 income up 20.8% at Rs 1,548 Cr; PAT up 74.3% at Rs 118 Cr. Network at 272 facilities in 10 countries. Board approved new wholly owned subsidiary in Ethiopia, shift of registered office to Alwarpet Chennai, and cessation as associate of Idearx (retains 14.54% stake).

Likely market impact

Strong revenue and profit growth; Ethiopia expansion and bigger network signal continued momentum for shareholders.